Status:
COMPLETED
Study of Lipid Control in Hyperlipidemic Participants (MK-0653-179)
Lead Sponsor:
Organon and Co
Conditions:
Dyslipidemia
Eligibility:
All Genders
30+ years
Brief Summary
This study is being done to see whether dietary and medicinal measures compliant with hyperlipidemia treatment guidelines will result in achieving target lipid values and to evaluate the total risk of...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Hyperlipidemic
- On therapy for hyperlipidemia for \>=3 months without achieving target lipid values
- Exclusion criteria:
- Hypersensitivity or intolerance to hypolipemics
- Significant myopathy or rhabdomiolysis probably caused by hypolipemics
- Uncontrolled endocrine or metabolic disease which is known to affect lipid or lipoprotein values (for example, hypothyroidism and hyperthyroidism)
Exclusion
Key Trial Info
Start Date :
December 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2013
Estimated Enrollment :
2196 Patients enrolled
Trial Details
Trial ID
NCT01436253
Start Date
December 1 2008
End Date
February 1 2013
Last Update
February 9 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.